BioNTech SE
BNTX
$107.34
-$0.16-0.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -437.57M | 276.62M | 217.79M | -869.46M | -342.07M |
| Total Depreciation and Amortization | 45.04M | 176.31M | 48.81M | 53.71M | 41.58M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.26M | -208.82M | -226.58M | 20.88M | -285.51M |
| Change in Net Operating Assets | -438.30M | -737.97M | -742.41M | 2.55B | 241.54M |
| Cash from Operations | -821.57M | -493.86M | -702.39M | 1.75B | -344.46M |
| Capital Expenditure | -51.46M | -70.99M | -80.03M | -95.36M | -63.51M |
| Sale of Property, Plant, and Equipment | 526.20K | 746.20K | 329.80K | 215.30K | -- |
| Cash Acquisitions | -82.61M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.45B | 716.97M | -76.52M | -164.68M | -2.44B |
| Cash from Investing | 1.31B | 646.72M | -156.22M | -259.83M | -2.50B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.80M | -7.30M | -7.90M | -22.90M | -7.80M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.52M | -7.78M | -8.69M | -24.65M | -8.47M |
| Foreign Exchange rate Adjustments | -16.94M | 14.50M | -2.53M | -3.55M | 7.38M |
| Miscellaneous Cash Flow Adjustments | -13.89M | -13.22M | 42.99M | 43.59M | -69.91M |
| Net Change in Cash | 445.14M | 146.36M | -826.84M | 1.51B | -2.92B |